| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| B467107-1mg |
1mg |
期货  |
| |
| B467107-5mg |
5mg |
现货 |
|
| 别名 | 6-(5-(噻吩-2-基)异恶唑-3-甲酰胺基)己基 5-((3a S ,4 S ,6a R )-2-氧代六氢-1 H -噻吩 [3,4- d 咪唑-4-基)戊酸酯 | 生物素标记异恶唑 |
|---|---|
| 英文别名 | B-Isox, 6-(5-(Thiophen-2-yl)isoxazole-3-carboxamido)hexyl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate, B-isox | B-Isox |
| 规格或纯度 | ≥95% |
| 英文名称 | Biotinylated isoxazole |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
应用 当暴露于细胞或组织裂解物时，生物素化异恶唑 (b-isox) 可沉淀 RNA 结合蛋白，与 RNA 颗粒的成分有明显重叠。通过与 RNA 颗粒相似的可逆性聚集和解聚结构，b-isox 有助于洞察 RNA 结合蛋白可逆性聚集所必需的多肽。本品之前被列为 T511617。 Description When exposed to cells or tissue lysates, biotinylated isoxazole (b-isox) was shown to precipitate RNA-binding proteins with significant overlap to the components of RNA granules. By reversibly aggregating and disaggregating structures similar to RNA granules, b-isox has lent insight to polypeptides necessary for the reversible aggregation of RNA-binding proteins.This product was previously listed as T511617. |
| PubChem SID | 488202574 |
|---|---|
| IUPAC Name | 6-[(5-thiophen-2-yl-1,2-oxazole-3-carbonyl)amino]hexyl 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate |
| INCHI | InChI=1S/C24H32N4O5S2/c29-21(10-4-3-8-20-22-17(15-35-20)26-24(31)27-22)32-12-6-2-1-5-11-25-23(30)16-14-18(33-28-16)19-9-7-13-34-19/h7,9,13-14,17,20,22H,1-6,8,10-12,15H2,(H,25,30)(H2,26,27,31)/t17-,20-,22-/m0/s1 |
| InChi Key | KZZXSHXZDYGEDW-XJABCFGWSA-N |
| Canonical SMILES | C1C2C(C(S1)CCCCC(=O)OCCCCCCNC(=O)C3=NOC(=C3)C4=CC=CS4)NC(=O)N2 |
| Isomeric SMILES | C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)OCCCCCCNC(=O)C3=NOC(=C3)C4=CC=CS4)NC(=O)N2 |
| PubChem CID | 97301453 |
| 分子量 | 520.66 |
| RIDADR | NONHforallmodesoftransport |
|---|
| Purity(HPLC area) | |
|---|---|
| Proton NMR spectrum | Conforms to Structure |
首页
400-620-6333
E2329580